Specific effects of biliopancreatic diversion on the major components of metabolic syndrome: A long-term follow-up study

Diabetes Care

Volumn 28, Issue 10, 2005, Pages 2406-2411

  Scopinaro, Nicola ^a,b   Marinari, Giuseppe Maria ^a   Camerini, Giovanni Bruno ^a   Papadia, Francesco Saverio ^a   Adami, Gian Franco ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTERIAL PRESSURE; ARTICLE; BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; CHOLESTEROL BLOOD LEVEL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; STOMACH BYPASS; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; BILIOPANCREATIC DIVERSION; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 25644459347     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.10.2406     Document Type: Article

References (52)

1. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL: The effect of age on the association between body mass index and mortality. N Engl J Med 338:1-7, 1998
2. Calle EE, Thun MJ, Petrelli MJ, Rodriguez C, Heath CW Jr: Body mass index and mortality in a prospective cohort of US adults. N Engl J Med 341:1097-1105, 1999
3. Ashton WD, Nanchahal K, Wood DA: Body mass index and metabolic risk factors for coronary heart disease in woman. Eur Heart J 22:46-55, 2001
4. Willett WC, Manson JE, Stampfer MJ, Colditz GA, Rosner B, Speizer FE, Hennekens CH: Weight, weight change, and coronary heart disease in women: risk within the 'normal' weight range. JAMA 273:461-465, 1995
5. Cho E, Manson JE, Stampfer MJ, Solomon CG, Colditz GA, Speizer FE, Willett WC, Hu FB: A prospective study of obesity and risk of coronary heart disease among diabetic women. Diabetes Care 25:1142-1148, 2002
6. Field AE, Coakley EH, Must A, Spadano JL, Laird N, Dietz WH, Rimm E, Colditz GA: Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med 161:1581-1586, 2001
7. Eckel RH: Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 96:3248-3250, 1997
8. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, Dohm L: Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 222:339-352, 1995
9. Rubino F, Gagner M: Potential of surgery for curing type 2 diabetes mellitus. Ann Surg 236:554-559, 2002
10. Pinkney J, Kerrigan D: Current status of bariatric surgery in the treatment of type 2 diabetes. Ob Rev 5:69-78, 2004
11. MacDonald KG Jr, Long SD, Swanson MS, Brown BM, Morris P, Dohm GL, Pories WJ: The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1:213-220, 1997
12. Scopinaro N, Adami GF, Marinari GM, Gianetta E, Traverse E, Friedman D, Camerini G, Baschieri G, Simonelli A: Biliopancreatic diversion. World J Surg 22: 936-946, 1998
13. Sugerman HJ, Wolfe LG, Sica DA, Clore JN: Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg 237:751-756, 2003
14. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, Eid GM, Mattar S, Ramanathan R, Barinas-Mitchel E, Rao RH, Kuller L, Kelley D: Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 238:467-484, 2003
15. Adami GF, Cordera R, Camerini G, Marinari GM, Scopinaro N: Recovery of insulin sensitivity in obese patients at short term after biliopancreatic diversion. J Surg Res 113:217-221, 2003
16. Mingrone G, DeGaetano A, Greco AV, Capristo E, Benedetti G, Castagneto M, Gasbarrini G: Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 40:599-605, 1997
17. Adami GF, Cordera R, Camerini G, Marinari GM, Scopinaro N: Long-term normalization of insulin sensitivity following biliopancreatic diversion for obesity. Int J Obes Relat Metab Disord 28:671-673, 2004
18. Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, Granzotto M, Vettor R, Camastra S, Ferrannini E: Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51:144-151, 2002
19. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 289: 2560-2571, 2000
20. Dixon JB, O'Brien PE: Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care 25:358-363, 2002
21. Dolan K, Bryant R, Fielding G: Treating diabetes in the morbidly obese by laparoscopic gastric banding. Obes Surg 13:439-443, 2003
22. Chapman AE, Kiroff G, Game P, Foster B, O'Brien P, Ham J, Maddern GJ: Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery 135:326-351, 2004
23. Ceelen W, Walder J, Cardon A, Van Renterghem K, Hesse U, El Malt M, Pattyn P: Surgical treatment of severe obesity with a low-pressure adjustable gastric band: experimental data and clinical results in 625 patients. Ann Surg 237:10-16, 2003
24. Björntorp P: "Portal" adipose tissue as a generator of risk factor for cardiovascular disease and diabetes. Arteriosclerosis 10: 493-496, 1990
25. Sarson DL, Scopinaro N, Bloom SR: Gut hormone changes after jeunoileal or biliopancreatic bypass surgery for morbid obesity. Int J Obes 5:471-476, 1981
26. Portes WJ, Albrecht RJ: Etiology of type II diabetes mellitus: role of the foregut. World J Surg 25:527-531, 2001
27. Rubino F, Marescaux J: Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 239:1-11, 2004
28. Scopinaro N, Marinari GM, Pretolesi F, Papadia F, Murelli F, Marini P, Adami GF: Energy and nitrogen absorption after biliopancreatic diversion. Obes Surg 10: 436-441, 2000
29. Randle PJ, Newsholme EA, Garland PB: Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochem J 93:652-665, 1964
30. Randle PJ, Garland PB, Newsholme EA, Hales CN: The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus. Ann N Y Acad Sci 131:324-333, 1965
31. Mingrone G, Rosa G, Greco AV, Manco M, Vega N, Nanni G, Castagneto M, Vidal H: Intramyocitic lipid accumulation and SREBP-1c expression are related to insulin resistance and cardiovascular risk in morbid obesity. Atherosclerosis 170:155-161, 2003
32. Mingrone G, Rosa G, Greco AV, Manco M, Vega N, Hesselink MK, Castagneto M, Schrauwen P, Vidal H: Decreased uncoupling protein expression and intramyocytic triglyceride depletion in formerly obese subjects. Obes Res 11:632-640, 2003
33. Unger RH: Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: genetic and clinical implications. Diabetes 44:863-870, 1995
34. McGarry JD: Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51:7-18, 2002
35. Gleysteen JJ, Barboriak JJ: Improvement in heart disease risk factors after gastric bypass. Arch Surg 118:681-684, 1983
36. Gonen B, Halverson JD, Schonfeld G: Lipoprotein levels in morbidly obese patients with massive, surgically-induced weight loss. Metabolism 32:492-496, 1983
37. Brolin RE, Bradley LJ, Wilson AC, Cody RP: Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg 4:464-469, 2000
38. Scopinaro N, Gianetta E, Civalleri D, Bonalumi U, Friedman D, Traverso E, Adami GF, Bachi V: Biliopancreatic bypass. In Surgical Management of Obesity. Griffen WO, Printen KJ, Eds. New York, Marcel, Dekker, and Basel, 1987, p. 93-161
39. Fuchs M: Bile acid regulation of hepatic physiology: III. Regulation of bile acid synthesis: past progress and future challenges. Am J Physiol Gastrointest Liver Physiol 284:G551-G557, 2003
40. Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science 232:34-47, 1986
41. Bilheimer DW, Grundy SM, Brown MS, Goldstein JL: Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes. Proc Natl Acad Sci U S A 80:4124-4128, 1983
42. Adami GF, Murelli F, Carlini F, Papadia F, Scopinaro N: Long-term effect of biliopancreatic diversion on blood pressure in hypertensive obese patients. Am J Hypertens 18:780-784, 2005
43. Carson JL, Ruddy ME, Duff AE, Holmes NJ, Cody RP, Brolin RE: The effect of gastric bypass surgery on hypertension in morbidly obese patients. Arch Intern Med 154:193-200, 1994
44. Foley EF, Benotti PN, Borlase BC, Hollingshead J, Blackburn GL: Impact of gastric restrictive surgery on hypertension in the morbidly obese. Am J Surg 163:294-297, 1992
45. Sjöström CD, Peltonen M, Wedel H, Sjöström L: Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 36:20-25, 2000
46. Sjöström CD, Peltonen M, Sjöström L: Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study. Obes Res 9:188-195, 2001
47. Ikeda T, Gomi T, Hirawa N, Sakurai J, Yoshikawa N: Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity. Hypertension 27:1180-1186, 1996
48. Raven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1605, 1988
49. Ferrannmi E, Haffner SM, Mitchell BD, Stern MP: Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabelologia 34:416-422, 1991
50. Gu K, Cowie CC, Harris MI: Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 21:1138-1145, 1998
51. Italian Institute of Statistics: La mortalità per causa nelle regioni Italiane [article online], 2002. Available from http://www. istat.it/dati/catalogo/20040728_00/. Accessed 11 August 2005
52. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998